Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Daniel Nettersheim

Showing results (21-30 of 73) with videos related to

Pageof 8
Sort By:
Genes, Chromosomes & Cancer|October 12, 2011
The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expressionDaniel Nettersheim, Ad Gillis, Katharina Biermann, et al.
Oncotarget|June 11, 2016
SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fateDaniel Nettersheim, Alena Heimsoeth, Sina Jostes, et al.
Genes, Chromosomes & Cancer|April 11, 2012
Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cellsDaniel Nettersheim, Birgit Westernströer, Natalie Haas, et al.
Pathologie (Heidelberg, Germany)|April 3, 2025
[Challenges in the research and diagnosis of rare diseases]Alexander Marx, Philipp Ströbel, Felix Bremmer, et al.
Urologie (Heidelberg, Germany)|September 9, 2025
[New insights from basic research on testicular germ cell tumors and updated tumorigenesis]Margaretha A Skowron, Lisa Schneider, Evangelos Prokakis, et al.
British Journal of Cancer|April 6, 2023
Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumoursKai Funke, Ulf Einsfelder, Aylin Hansen, et al.
International Journal of Cancer|October 5, 2019
Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fateSina V Jostes, Martin Fellermeyer, Lena Arévalo, et al.
Epigenetics|October 9, 2010
NANOG promoter methylation and expression correlation during normal and malignant human germ cell developmentDaniel Nettersheim, Katharina Biermann, Ad J M Gillis, et al.
Oncotarget|August 31, 2016
A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatmentDaniel Nettersheim, Sina Jostes, Martin Fabry, et al.
Journal of Cellular and Molecular Medicine|December 20, 2024
The New Tumour Biomarker miRNA-371-3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell LinesRichard Weiten, Theadora Engler, Hubert Schorle, et al.
Pageof 8

Showing results (21-30 of 73) with videos related to

Sort By:
Pageof 8
Genes, Chromosomes & Cancer|October 12, 2011
The seminoma cell line TCam-2 is sensitive to HDAC inhibitor depsipeptide but tolerates various other chemotherapeutic drugs and loss of NANOG expressionDaniel Nettersheim, Ad Gillis, Katharina Biermann, et al.
Oncotarget|June 11, 2016
SOX2 is essential for in vivo reprogramming of seminoma-like TCam-2 cells to an embryonal carcinoma-like fateDaniel Nettersheim, Alena Heimsoeth, Sina Jostes, et al.
Genes, Chromosomes & Cancer|April 11, 2012
Establishment of a versatile seminoma model indicates cellular plasticity of germ cell tumor cellsDaniel Nettersheim, Birgit Westernströer, Natalie Haas, et al.
Pathologie (Heidelberg, Germany)|April 3, 2025
[Challenges in the research and diagnosis of rare diseases]Alexander Marx, Philipp Ströbel, Felix Bremmer, et al.
Urologie (Heidelberg, Germany)|September 9, 2025
[New insights from basic research on testicular germ cell tumors and updated tumorigenesis]Margaretha A Skowron, Lisa Schneider, Evangelos Prokakis, et al.
British Journal of Cancer|April 6, 2023
Genome-scale CRISPR screen reveals neddylation to contribute to cisplatin resistance of testicular germ cell tumoursKai Funke, Ulf Einsfelder, Aylin Hansen, et al.
International Journal of Cancer|October 5, 2019
Unique and redundant roles of SOX2 and SOX17 in regulating the germ cell tumor fateSina V Jostes, Martin Fellermeyer, Lena Arévalo, et al.
Epigenetics|October 9, 2010
NANOG promoter methylation and expression correlation during normal and malignant human germ cell developmentDaniel Nettersheim, Katharina Biermann, Ad J M Gillis, et al.
Oncotarget|August 31, 2016
A signaling cascade including ARID1A, GADD45B and DUSP1 induces apoptosis and affects the cell cycle of germ cell cancers after romidepsin treatmentDaniel Nettersheim, Sina Jostes, Martin Fabry, et al.
Journal of Cellular and Molecular Medicine|December 20, 2024
The New Tumour Biomarker miRNA-371-3p Influences Cisplatin Sensitivity of Testicular Germ Cell Tumour Cell LinesRichard Weiten, Theadora Engler, Hubert Schorle, et al.
Pageof 8